Skip to main content

Trinity College Dublin, The University of Dublin

Trinity Menu Trinity Search



You are here People

Prof. Anne Marie Healy B.Sc. (Pharm.), Ph.D., M.P.S.I, F.T.C.D.

Pharmaceutics and Pharmaceutical Technology

 Professor
 Email: healyam@tcd.ie
 Phone: +353-1-896-1444
 Location: Panoz Institute, Trinity College Dublin, Dublin 2, Ireland.

 

 

RESEARCH INTERESTS

Anne Marie Healy is Professor of Pharmaceutics and Pharmaceutical Technology in the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin and is one of the Co-Directors of the Centre for Doctoral Training in Transformative Pharmaceutical Technologies. She is also Co-Principal Investigator of SSPC - the Science Foundation Ireland Research Centre for Pharmaceuticals, and was awarded the SSPC Researcher of the Year in 2019. This award recognises Anne Marie’s many contributions to the Centre with exceptional scientific outputs.

Her research interests include pharmaceutical material science, preformulation and formulation of pharmaceuticals, amorphous solids, co-crystals, formulating poorly soluble drugs, pharmaceutical processing and pulmonary drug delivery.

Anne Marie has a B.Sc. in Pharmacy and a Ph.D. in Pharmaceutics, both from the University of Dublin. She joined the School of Pharmacy, TCD in 1992 as a Lecturer in Pharmaceutics. In 2010 she was elected Fellow of Trinity College.

Professor Healy has published extensively, with over 100 international peer reviewed publications. She has graduated 20 PhD students, mentored 25 postdoctoral researchers, and has been awarded €10 million in competitive grant income.

Professor Healy has received funding from both national and international agencies to progress her research. As well as her involvement as Co-PI with the SSPC, she has held a Science Foundation Ireland Principal Investigator award focused on the development of fixed dose combination products using advanced pharmaceutical processing technologies. She has also received NIH funding to work on a collaborative project with the University of California, San Francisco and University College Dublin aimed at developing novel mucolytic therapies for lung disease. She was awarded a Special Visiting Researcher Fellowship by CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil) in 2014 to further her collaborative research with the Faculty of Pharmacy of the Federal University of Rio de Janeiro.

FINANCIAL SUPPORT

Science Foundation Ireland, Enterprise Ireland, Irish Research Council, CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil), National Institutes of Health (NIH, USA), numerous pharmaceutical companies including: APC, Xeolas, IVAX Pharmaceuticals, Merrion Pharmaceuticals, Velox GmbH, Amebis, Solvotrin Therapeutics, Pfizer, GSK, Merck, Eli Lilly, Janssen, Roche, Bristol-Myers Squibb, Alkermes, UCB Pharma, Abbvie, Clarochem, Innopharma Labs, Glantreo, Dynochem, Eirgen, Novartis, Allergan, Genzyme, Biomarin, FMC, SK Biotek.

PUBLICATIONS

Publications